Enterocolitis
-
Danisco BioActives and Sigma-Tau Pharmaceuticals Announce Partnership Agreement
Danisco BioActives and Sigma-Tau Pharmaceuticals have signed a partnering agreement for the development of a biologic drug candidate which may help to prevent Necrotizing Enterocolitis (NEC). Under the terms of the agreement, the companies will co…
Enterocolitis | 21 April 2009
